NCT05237284 Phase 2 Study for SAR443820 in Participants With Amyotrophic Lateral Sclerosis (ALS) Status TERMINATED Phase PHASE2
NCT05218668 Rho Kinase Inhibitor in Amyotrophic Lateral Sclerosis (REAL) Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05204017 Comprehensive Analysis Platform To Understand, Remedy and Eliminate ALS Status RECRUITING Phase N/A
NCT05189106 Neurodegenerative Alzheimer's Disease and Amyotrophic Lateral Sclerosis (NADALS) Basket Trial Status COMPLETED Phase PHASE1/PHASE2
NCT05178810 Study to Investigate the Efficacy and Safety of FAB122 (Daily Oral Edaravone) in Patients With Amyotrophic Lateral Sclerosis Status COMPLETED Phase PHASE3
NCT05176093 A 6-Month Extension Study to Assess the Long-Term Safety of Engensis in Amyotrophic Lateral Sclerosis Status COMPLETED Phase PHASE2
NCT05163886 Study of Safety, Tolerability, and Biological Activity of LAM-002A in C9ORF72-Associated Amyotrophic Lateral Sclerosis Status COMPLETED Phase PHASE2
NCT05151211 Use of 1 Minute Sit to Stand Test for Physical Capacity and Effort Related Desaturation in Amyotrophic Lateral Sclerosis Status NOT_YET_RECRUITING Phase N/A
NCT05137665 Target ALS Biomarker Study; Longitudinal Biofluids, Clinical Measures, and At Home Measures Status RECRUITING Phase N/A
NCT05136885 HEALEY ALS Platform Trial - Regimen E SLS-005 - Trehalose Status COMPLETED Phase PHASE2/PHASE3
NCT05116943 Biospecimen Biorepository for the Study of ALS, ALS-FTD and Similar Neurodegenerative Disorders Status RECRUITING Phase N/A
NCT05107349 Cell Signaling, Reinnervation and Metabolism in Kennedy Disease and Amyotrophic Lateral Sclerosis (ALS) Status RECRUITING Phase NA
NCT05105958 Tideglusib for the Treatment of Amyotrophic Lateral Sclerosis Status NOT_YET_RECRUITING Phase PHASE2
NCT05095571 A Trial of Nicotinamide/Pterostilbene Supplement in ALS: The NO-ALS Extension Study Status RECRUITING Phase NA